Skip to main content

Featured

The Subway That Took a Generation: Why the Eglinton Crosstown’s Delays Were Even Worse Than You Think

  Toronto has a long history of transit projects that drag on, but the Eglinton Crosstown LRT has become the city’s defining example of how complicated, political, and painfully slow building transit can be. Most people think of the project as something that started in the early 2010s and simply ran over schedule. The truth is far messier—and stretches back decades. A Project With Roots in the 1990s Long before shovels hit the ground in 2011, the idea of rapid transit along Eglinton was already alive. In the mid‑1990s, the TTC began digging tunnels for what was then called the Eglinton West Subway . Construction actually started—tunnels were being carved out under the street—until the project was abruptly cancelled in 1995. The partially built tunnels were filled in, and the corridor sat untouched for years. That early false start meant that by the time the Crosstown was revived as part of the Transit City plan in 2007, planners weren’t starting fresh. They were restarting a dr...
Post a Comment
Read more

article

Labels

Stock Futures Steady as Investors Await Fresh Jobs Data

U.S. stock futures were little changed on Thursday as Wall Street attempted to recover from recent declines. Futures tied to the S&P 500 were flat, while Nasdaq futures rose slightly. Dow Jones Industrial Average futures fell marginally.

Labor Market Update: Today’s spotlight is on the release of the report on initial weekly jobless claims. A positive number could reassure traders about the state of the jobs market, while a negative one may introduce more turbulence. Last week’s sluggish non-farm payrolls update was one of the catalysts for recent declines.

Individual Movers:

  • Nvidia (NVDA): The AI giant’s stock is in focus after a back-and-forth day left it down another 5%.
  • Eli Lilly (LLY): The company’s stock soared over 10% in premarket trading after boosting its annual revenue and profit forecasts on strong weight-loss drug sales.


Labels:

Comments

Post a Comment